Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fish and Richardson
Cipla
Federal Trade Commission
Colorcon
Chubb
McKinsey
UBS
Cerilliant

Generated: June 18, 2018

DrugPatentWatch Database Preview

CEDAX Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Cedax, and when can generic versions of Cedax launch?

Cedax is a drug marketed by Si Pharms and is included in two NDAs.

The generic ingredient in CEDAX is ceftibuten dihydrate. One supplier is listed for this compound. Additional details are available on the ceftibuten dihydrate profile page.
Summary for CEDAX
US Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: 1
Bulk Api Vendors: 32
Patent Applications: 2,931
DailyMed Link:CEDAX at DailyMed
Drug patent expirations by year for CEDAX
Pharmacology for CEDAX
Synonyms for CEDAX
(+)-(6R,7R)-7-((Z)-2-(2-Amino-4-thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
(6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-4-carboxybut-2-enamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-4-carboxy-1-oxo-2-buten-1-yl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-4-carboxy-1-oxo-2-buten-1-yl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate
(6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((2-(2-amino-4-thiazolyl)-4-carboxy-1-oxo-2-butenyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))-
519C396
7432-S
7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-3,4-didehydrocepham-4-carboxylic acid
97519-39-6
AB01563048_01
AC1NQZPP
AKOS005146205
AKOS015854930
Antibiotic 7432S
BDBM50370586
BSPBio_002733
C08117
CAS-97519-39-6
CC0255
CCG-39440
Ceftem
ceftibuten
Ceftibuten (USAN/INN)
Ceftibuten [USAN:INN:BAN]
CEFTIBUTEN DIHYDRATE
Ceftibuten hydrate
Ceftibuten, Antibiotic for Culture Media Use Only
Ceftibutene
Ceftibutene [INN-French]
Ceftibuteno
Ceftibuteno [INN-Spanish]
Ceftibutenum
Ceftibutenum [INN-Latin]
Cephalosporin 7432-S
Cephem
Ceprifran
CHEBI:3510
CHEMBL1605
cis-ceftibuten
cis-Ceftibutin
CS-2939
D00922
DB01415
DR002450
DSSTox_CID_25925
DSSTox_GSID_45925
DSSTox_RID_81227
DTXSID4045925
HE420318
HMS1922L17
HMS2093K18
HY-B0698
I14-31895
Isocef
IW71N46B4Y
Keimax
MFCD00864918
MolPort-003-666-607
NCGC00095137-01
NCGC00178501-01
NSC-758925
NSC758925
Pharmakon1600-01505207
S 7432
SBI-0206740.P001
SC-27736
Sch 39720
Sch-39720
SCHEMBL37054
SPECTRUM1505207
Spectrum5_001558
SR-05000001989
SR-05000001989-1
Tox21_111446
UNII-IW71N46B4Y
ZINC3871967

US Patents and Regulatory Information for CEDAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Si Pharms CEDAX ceftibuten dihydrate CAPSULE;ORAL 050685-002 Dec 20, 1995 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-001 Dec 20, 1995 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-002 Dec 20, 1995 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for CEDAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-001 Dec 20, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-001 Dec 20, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-002 Dec 20, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Si Pharms CEDAX ceftibuten dihydrate CAPSULE;ORAL 050685-002 Dec 20, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Fuji
Federal Trade Commission
Colorcon
McKinsey
Queensland Health
Cerilliant
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.